Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences

Atypical antipsychotics (AAPs) are commonly prescribed medications to treat schizophrenia, bipolar disorders and other psychotic disorders. However, they might cause metabolic syndrome (MetS) in terms of weight gain, dyslipidemia, type 2 diabetes (T2D), and high blood pressure, which are responsible...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmaceuticals (Basel)
Hlavní autoři: Carli, Marco, Kolachalam, Shivakumar, Longoni, Biancamaria, Pintaudi, Anna, Baldini, Marco, Aringhieri, Stefano, Fasciani, Irene, Annibale, Paolo, Maggio, Roberto, Scarselli, Marco
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8001502/
https://ncbi.nlm.nih.gov/pubmed/33800403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14030238
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky